Sun Pharma Q2

                    

Cons Profit At Rs 2235 Cr Vs CNBC-TV18 Poll Of Rs1,685 Cr, 

Cons Income At Rs 8,265 Cr Vs Poll Of Rs 7,772.8 Cr

Cons EBITDA At Rs 3,167.7 Cr Vs CNBC-TV18 Poll Of Rs 2,487 Cr, 

Cons EBITDA Margin At 38.3% Vs Poll Of 32%